No Data
Hong Kong stock movement | JXR (01951) surged nearly 5% during the session. Institutions indicated that the company benefits from stimulus policies with significant growth in overseas business.
JXR (01951) surged nearly 5% during the trading session, up 4.5% as of the time of writing, priced at 3.25 Hong Kong dollars, with a transaction value of 0.0106 million Hong Kong dollars.
News Flash: 13 Analysts Think Jinxin Fertility Group Limited (HKG:1951) Earnings Are Under Threat
[Brokerage Focus] BOCOM INTL maintains a Buy rating on JXR (01951) with a more optimistic expectation for performance in 2026 and the long term.
Gold Eagle Financial News | BOCOM INTL Research Reports indicate that JXR (01951) expects a revenue growth of 1% and a decline of 12% in adjusted Net income for 2024. The number of cycles in Chengdu's Business decreased by 13%, but revenue saw a slight increase due to higher demand in obstetrics, pediatrics, and high-end Medical Services that drove up the ASP. Among the incubating Institutions, the number of cycles in Wuhan grew by 40%, while Yunnan remained essentially flat after excluding the impact of renovations. Overseas Business revenue and the number of cycles increased by 6% and 18% respectively. The bank noted that policy benefits are gradually being realized: Hohhot recently released the implementation details for childcare subsidies, and the bank expects more regions to follow suit.
Investors who bought high-level pharmaceutical Funds have hope! More than 80% of products achieved positive returns in the first quarter, and recovering losses is promising.
① A total of 264 medical Funds had positive returns in the first quarter of this year, accounting for over 80%, with many Funds achieving returns exceeding 15% this year. ② The net value of medical Funds established in 2020 and 2021 is currently being repaired, and investors who entered at high levels are expected to break even.
Hong Kong stocks movement | JXR (01951) rose nearly 6% in the afternoon. Institutions stated that fertility support policies provide long-term growth potential, while short-term benefits for the Industry remain limited.
JXR (01951) rose nearly 6% in the afternoon, as of this report, it is up 4.65%, at 3.15 HKD, with a trading volume of 0.251 billion HKD.
Understanding JXR (1951.HK) full-year performance in 2024 at a glance.
Recently, JXR released its annual performance results for the year ending December 31, 2024, which will be explained in detail through an infographic.
Insider Spends CN¥3.6m Buying More Shares In Jinxin Fertility Group
